Day: August 12, 2022

SEOUL, South Korea, Aug. 12, 2022 /PRNewswire/ — ROKIT Healthcare, a company specializing in bio-healthcare, today announced it will provide a hyper-personalized medical platform that uses 3D bioprinting and AI technology built on Google Cloud, to innovate the treatment of osteoarthritis and diabetes feet. ROKIT Healthcare’s AI solution accurately recognizes the affected area of the patient, using computer vision and deep-learning technology, and then outputs a patch with the same size and shape as the affected area to a 3D printer. The goal for this platform is to increase the treatment rate for chronic and complex diseases, improve access to medically underprivileged areas, and lower medical expenses.

ROKIT Healthcare moved its existing infrastructure to Google Cloud and used Google Cloud’s AI tools to expand its medical platform. ROKIT Healthcare has established a system that can reliably expand and operate medical platforms in various regions using Google Cloud’s scalable, high-performance load-balancing service Cloud Load Balancing and Google Kubernetes Engine (GKE), which provide a fully managed Kubernetes service.

Currently, ROKIT Healthcare has signed 10-year contracts with its customers worth about KRW 2.5 trillion in 20 countries around the world, increasing the number of countries in which it operates, such as UAE, Brazil, Malaysia, India, Turkiye, and Paraguay.

Andrew Chang, Managing Director of Google Cloud Korea, said, “This cooperation with ROKIT is very meaningful in that the company will be able to provide innovative treatment solutions for chronic diseases that have not previously been treated sufficiently. I’m pleased that we can help increase the reliability and scalability of ROKIT Healthcare’s medical platform with Google Cloud solutions, including Vertex AI.”

You Seok-hwan, CEO of ROKIT Healthcare, said, “We are confident that ROKIT Healthcare has introduced a leading system in the field of personalized regeneration including skin and cartilage. Through this cooperation with Google Cloud, ROKIT Healthcare expects to realize its vision to transform the medical paradigm more quickly. ROKIT Healthcare will build a medical platform that can tap the collective intelligence of doctors all over the world and quickly spread solutions that can cure disease in a short time at a low cost.”

Photo – https://mma.prnewswire.com/media/1875631/image_1.jpg

NINGDE, China, Aug. 12, 2022 /PRNewswire/ — On August 12, 2022, Contemporary Amperex Technology Co., Limited (CATL) officially announced it will invest 7.34 billion euros to build a 100 GWh battery plant in Debrecen of east Hungary, which is also its second battery plant in Europe following its German plant. Subject to the shareholder meeting approval, construction of the first production facilities will start within this year.

Covering an area of 221 hectares in the Southern Industrial Park of Debrecen, the project will supply both cells and modules to European automakers.

Debrecen is located at the heart of Europe, and with close proximity to some auto plants of its customers such as Mercedes-Benz, BMW, Stellantis and Volkswagen, CATL’s Debrecen plant will enable it to better cope with the battery demands of the European market, improve its global production network development, and help accelerate e-mobility and energy transition in Europe.

As part of its commitment to reducing the carbon footprint in battery manufacturing, CATL will use electricity from renewable energies, and is considering developing solar power with local partners in the country.

To build a sustainable and circular battery value chain, CATL is also examining the possibility of joining forces with local partners to establish facilities for battery materials in Europe.

“There is no doubt that our plant in Debrecen will enable us to further sharpen our competitive edge, better respond to our European customers, and accelerate the transition to e-mobility in Europe,” said Dr. Robin Zeng, founder and Chairman of CATL. “The greenfield project in Hungary will be a giant leap in CATL’s global expansion, and also an important step in our efforts to make an outstanding contribution to the green energy drive for humankind.”

Péter Szijjártó, Hungarian Minister of Foreign Affairs and Trade, said: “Both the global and the European economies have been faced with tremendous challenges recently. We in Hungary have a clear goal to be a local exception from the continental recession. The best tool to achieve this goal is to attract state-of-the-art investments in the most revolutionary branch of the automotive industry, namely electromobility. We are proud that CATL decided to execute the biggest ever greenfield investment in the history of Hungary. We have recently become one of the leading battery production sites of the world and with this huge investment we further strengthen our position.”

The new project was well received from CATL’s European customers. Markus Schäfer, Member of the Board of Management of Mercedes-Benz Group AG, CTO responsible for development and procurement, said: “This new state-of-the art European CATL plant in Hungary is another milestone for the scale-up of our EV production together with our key partners. With CATL we have a technology-leader as our partner to provide us – as the first and biggest customer of the new plant’s initial capacity – with top-notch CO2 neutral battery cells for our next generation EVs in Europe, hence following our local-to-local approach in procurement. We’re proud to see our Ambition 2039 supported by CATL’s commitment to CO2 neutral production in Hungary.”

Photo – https://mma.prnewswire.com/media/1877209/1.jpg
Photo – https://mma.prnewswire.com/media/1877208/2.jpg